Carboplatin-containing regimens as front-line treatment for advanced non-small-cell lung cancer in two groups of elderly

References

• Pallis AG, Gridelli C, van Meerbeeck JP, Greillier L, Wedding U, Lacombe D, et al.. EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts opinion for the treatment of non-small-cell lung cancer in an elderly population. Ann Oncol. 2010;21:692–706.
   PubMed Web of Science ®Google Scholar
• Pirker R. Advanced NSCLC-should we use doublets in elderly patients? Nat Rev Clin Oncol. 2011;8:694–6.
   PubMed Web of Science ®Google Scholar
• Pallis AG, Fortpied C, Wedding U, Van Nes MC, Pennincks B, Ring A, et al.. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer. 2010;46:1502–13.
   PubMed Web of Science ®Google Scholar
• Davidoff AJ, Tang M, Seal B, Edelman MJ. Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer. Cancer J. 2010;28:2191–7.
   Google Scholar
• Quoix E, Monnet L, Scheid P Hamadouche A, Chouaid C, Massard G, et al.. Management and outcome of French elderly patients with lung cancer: an IFCT survey. Rev Mal Respir. 2010;27:421–30.
   PubMed Web of Science ®Google Scholar
• Covey HC. The definitions of the beginning of old age in history. Int J Aging Hum Dev. 1992;34:325–37.
   PubMed Web of Science ®Google Scholar
• Gravina CF, Batlouni M, Sarteschi C, Sousa AG, Sousa JE, Piegas L. Influence of age and coronary artery disease on homocysteine levels in the young old compared with the old old and the oldest old. Am J Geriatr Cardiol. 2006;15:165–73.
   PubMedGoogle Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
   PubMedGoogle Scholar
• The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst. 1999;91:66–72.
   PubMed Web of Science ®Google Scholar
• Gridelli C, Perrone F, Gallo C, Cigolari S, Rossi A, Piantedosi F, et al.. Chemotherapy of elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst. 2003;95:362–72.
   PubMed Web of Science ®Google Scholar
• Pfister DG, Johnson DH, Azzoli CG, Sause W, Smith TJ, Baker S Jr, et al.. American Society of Clinical Oncology Treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol. 2004;22:330–53.
   PubMed Web of Science ®Google Scholar
• Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavolé A, et al.. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet. 2011;378:1079–88.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc. 1958;53:457–81.
   Web of Science ®Google Scholar
• Chemotheray in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ. 1995;311:899–909.
   PubMed Web of Science ®Google Scholar
• Vamvakas L, Saloust E, Karampeazis A, Vassilis G. Advanced non-small-cell lung cancer in the elderly. Clin Lung Cancer. 2009;10:158–67.
   PubMed Web of Science ®Google Scholar
• Tsukada H, Yokoyama A, Nishiwaki Y, Shinkai T, Harada M, Ando M, et al.. Randomised controlled trial comparing doctexel (D) – cisplatin (P) combination with D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): JCOG0207. Proc Am Soc Clin Oncol. 2007;25:Abstract 7629.
   Google Scholar
• Abe T, Yokoyama A, Takeda K, Ohe Y, Kudoh S, Ichinose Y, et al.. Randomized phase III trial comparing weekly docetaxel (D)-cisplatin (P) combination with triweekly D alone in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC): an intergroup trial of JCOG0803/WJOG4307L. Proc Am Soc Clin Oncol. 2011;29:Abstract 7099.
   Google Scholar
• Chen YM, Perng RP, Shih JF, Whang-Peng J. A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly. Lung Cancer. 2008;61:214–9.
   PubMed Web of Science ®Google Scholar
• Kusagaya H, Inui N, Karayama M, Nakamura Y, Kuroishi S, Yokomura K, et al.. Biweekly combination therapy with gemcitabine and carboplatin compared with gemcitabine monotherapy in elderly patients with advanced non-small-cell lung cancer: a randomized, phase–II study. Lung Cancer. 2012;77:550–5.
   PubMed Web of Science ®Google Scholar
• Maestu I, Gómez-Aldaraví L, Torregrosa MD, Camps C, Llorca C, Bosch C, et al.. Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer. Lung Cancer. 2003;42:345–54.
   PubMed Web of Science ®Google Scholar
• Takatani H, Nakamura Y, Nagashima S, Nakamura Y, Kuroishi S, Yokomura K, et al.. Phase I and II trials of vinorelbine with carboplatin for patients 75 years of age or older with previously untreated non-small-cell lung cancer. Clin Lung Cancer. 2012;13:347–51.
   PubMed Web of Science ®Google Scholar
• Gervais R, Robinet G, Clément-Duchene C, Denis F, Kouri CE, Martin P, et al.. Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): a phase II trial. Lung Cancer. 2013;80:185–90.
   PubMed Web of Science ®Google Scholar
• Ardizzoni A, Boni L, Tiseo M, Fossella FV, Schiller JH, Paesmans M, et al.. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst. 2007;11:847–57.
   Google Scholar
• Extermann M, Overcash J, Lyman GH, Parr J, Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16:1582–7.
   PubMed Web of Science ®Google Scholar